A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-08) →
What happened
OliX Pharmaceuticals disclosed a private placement (third-party allotment) to raise US$6.83M, about 0.4% of its market value.
For context, this raise equals about 0.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$6.83M |
| vs. market value | 0.4% |
| Filed | 2026-06-29, Material event report (rights offering) |
| Source | DART rcept 20260629000494 → open original filing |
Versions of this filing
- 2026-06-29Original (this page)
- 2026-07-08Amendment 1
Source: DART. Information only, not investment advice.